SE9701127D0 - Antigenic fusionprotein carrying GALal, 3GAL epitopes - Google Patents

Antigenic fusionprotein carrying GALal, 3GAL epitopes

Info

Publication number
SE9701127D0
SE9701127D0 SE9701127A SE9701127A SE9701127D0 SE 9701127 D0 SE9701127 D0 SE 9701127D0 SE 9701127 A SE9701127 A SE 9701127A SE 9701127 A SE9701127 A SE 9701127A SE 9701127 D0 SE9701127 D0 SE 9701127D0
Authority
SE
Sweden
Prior art keywords
polypeptide
galal
fusion protein
plasma
blood
Prior art date
Application number
SE9701127A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Holgersson
Jining Liu
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9701127A priority Critical patent/SE9701127D0/xx
Publication of SE9701127D0 publication Critical patent/SE9701127D0/xx
Priority to EP06075010A priority patent/EP1700868A3/en
Priority to DK98912863T priority patent/DK0923606T3/da
Priority to ES98912863T priority patent/ES2258297T3/es
Priority to JP54556998A priority patent/JP4099239B2/ja
Priority to BR9804826-0A priority patent/BR9804826A/pt
Priority to AU67551/98A priority patent/AU751760B2/en
Priority to PCT/SE1998/000555 priority patent/WO1998042750A1/en
Priority to AT98912863T priority patent/ATE315047T1/de
Priority to DE69833106T priority patent/DE69833106T2/de
Priority to US09/194,396 priority patent/US6943239B2/en
Priority to EP98912863A priority patent/EP0923606B1/en
Priority to CA002255765A priority patent/CA2255765A1/en
Priority to US11/153,082 priority patent/US20050255099A1/en
Priority to US12/507,626 priority patent/US20090286963A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9701127A 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes SE9701127D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9701127A SE9701127D0 (sv) 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes
CA002255765A CA2255765A1 (en) 1997-03-26 1998-03-26 Antigenic fusionprotein carrying gal.alpha.1,3gal epitopes
AU67551/98A AU751760B2 (en) 1997-03-26 1998-03-26 Antigenic fusionprotein carrying galalpha1,3Gal epitopes
AT98912863T ATE315047T1 (de) 1997-03-26 1998-03-26 Antigene fusionsproteine, die gal-alpha-1,3-gal- epitope enthalten.
ES98912863T ES2258297T3 (es) 1997-03-26 1998-03-26 Proteina de fusion antigenica portadora de epitopos gal-alfa-1,3gal.
JP54556998A JP4099239B2 (ja) 1997-03-26 1998-03-26 ＧＡＬα１、３ＧＡＬエピトープを有する抗原性融合タンパク質
BR9804826-0A BR9804826A (pt) 1997-03-26 1998-03-26 Proteìna de fusão antigênica portando epìtopos galoc 1,3 gal
EP06075010A EP1700868A3 (en) 1997-03-26 1998-03-26 A method for removing an antibody from blood or plasma
PCT/SE1998/000555 WO1998042750A1 (en) 1997-03-26 1998-03-26 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES
DK98912863T DK0923606T3 (da) 1997-03-26 1998-03-26 Antigent fusionsprotein med GALALPHA1,3GAL epitoper
DE69833106T DE69833106T2 (de) 1997-03-26 1998-03-26 Antigene fusionsproteine, die gal-alpha-1,3-gal-epitope enthalten.
US09/194,396 US6943239B2 (en) 1997-03-26 1998-03-26 Antigenic fusionprotein carrying Galα1,3Gal epitopes
EP98912863A EP0923606B1 (en) 1997-03-26 1998-03-26 Antigenic fusionprotein carrying galalpha1,3gal epitopes
US11/153,082 US20050255099A1 (en) 1997-03-26 2005-06-15 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes
US12/507,626 US20090286963A1 (en) 1997-03-26 2009-07-22 Antigenic fusion protein carrying gal alpha1,3gal epitopes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701127A SE9701127D0 (sv) 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes

Publications (1)

Publication Number Publication Date
SE9701127D0 true SE9701127D0 (sv) 1997-03-26

Family

ID=20406335

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701127A SE9701127D0 (sv) 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes

Country Status (12)

Country Link
US (3) US6943239B2 (pt)
EP (2) EP0923606B1 (pt)
JP (1) JP4099239B2 (pt)
AT (1) ATE315047T1 (pt)
AU (1) AU751760B2 (pt)
BR (1) BR9804826A (pt)
CA (1) CA2255765A1 (pt)
DE (1) DE69833106T2 (pt)
DK (1) DK0923606T3 (pt)
ES (1) ES2258297T3 (pt)
SE (1) SE9701127D0 (pt)
WO (1) WO1998042750A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002321760B9 (en) * 2001-07-20 2008-06-12 Absorber, Ab Blood group antigen fusion polypeptides and methods of use thereof
US8034351B2 (en) * 2002-04-22 2011-10-11 Recopharma Ab Mucin fusion polypeptide vaccines, compositions and methods of use thereof
WO2003089450A2 (en) * 2002-04-22 2003-10-30 Recopharma Ab Fusion polypeptides and methods for inhibiting microbial adhesion
CA2486106C (en) * 2002-05-16 2013-07-16 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
CA2490703A1 (en) * 2002-07-03 2004-01-15 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US7638323B2 (en) * 2002-08-09 2009-12-29 Recopharma Ab Fusion proteins and methods of producing same
US20050076759A1 (en) * 2003-10-08 2005-04-14 Brian Westfall Linear saw with stab-cut bevel capability
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US7459523B2 (en) * 2003-11-12 2008-12-02 Wisconsin Alumni Research Foundation Equine P-selectin glycoprotein ligand-1 and uses thereof
CA2546784A1 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
EP1763533B1 (en) * 2003-11-19 2008-01-09 GlycoMimetics, Inc. Specific antagonist for both e- and p-selectins
WO2006001348A1 (ja) * 2004-06-23 2006-01-05 Japan Science And Technology Agency 浸潤抑制及び細胞殺傷剤
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
CN101291946B (zh) * 2005-08-09 2011-06-29 糖模拟物有限公司 对来自假单胞菌的pa-il凝集素、pa-iil凝集素或其两者的糖模拟物抑制剂
LT2264043T (lt) 2005-09-02 2017-12-11 Glycomimetics, Inc. Heterobifunkciniai pan-selektino inhibitoriai
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
WO2007132355A2 (en) * 2006-01-26 2007-11-22 Recopharma Ab Compositions and methods for inhibiting viral adhesion
US20070178447A1 (en) * 2006-01-31 2007-08-02 Bethyl Laboratories, Inc. Method for decreasing interference in results of immunochemical methods
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
EP2074132B1 (en) 2006-10-12 2013-05-15 GlycoMimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
US7998486B2 (en) 2006-10-25 2011-08-16 Newlink Genetics Corporation Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
ES2426784T3 (es) * 2008-06-13 2013-10-25 Glycomimetics, Inc. Tratamiento de cánceres de la sangre usando compuestos glicomiméticos seleccionados
WO2010126888A1 (en) 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
CA2821969A1 (en) * 2010-12-21 2012-06-28 Recopharma Ab Tear substitutes
CA2858099C (en) 2011-12-22 2020-12-15 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
DK2928476T3 (en) 2012-12-07 2018-05-22 Glycomimetics Inc RELATIONSHIPS, COMPOSITIONS AND METHODS OF USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS
DK3227310T3 (da) 2014-12-03 2019-09-30 Glycomimetics Inc Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
WO2018068010A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3091454A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
WO2019241386A1 (en) * 2018-06-12 2019-12-19 Rush University Medical Center Methods for enhanced endothelialization of implanted material
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580812A1 (en) * 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Ctla4 receptor, fusion proteins containing it and uses thereof
CA2497857C (en) * 1992-10-23 2009-05-26 Genetics Institute, Llc Novel p-selectin ligand protein
EP1621627A3 (en) 1993-03-16 2006-06-07 The Austin Research Institute Use of porcine gala (1,3) galactosyl transferase in xenograft therapies
GB9517758D0 (en) * 1995-08-31 1995-11-01 Imutran Ltd Compositions and their uses

Also Published As

Publication number Publication date
EP1700868A2 (en) 2006-09-13
EP0923606A1 (en) 1999-06-23
WO1998042750A1 (en) 1998-10-01
DK0923606T3 (da) 2006-05-22
EP0923606B1 (en) 2006-01-04
DE69833106T2 (de) 2006-08-31
AU751760B2 (en) 2002-08-29
JP2000511782A (ja) 2000-09-12
US20050255099A1 (en) 2005-11-17
US20090286963A1 (en) 2009-11-19
EP1700868A3 (en) 2007-12-12
BR9804826A (pt) 2000-01-25
CA2255765A1 (en) 1998-10-01
ES2258297T3 (es) 2006-08-16
ATE315047T1 (de) 2006-02-15
US20020028205A1 (en) 2002-03-07
AU6755198A (en) 1998-10-20
JP4099239B2 (ja) 2008-06-11
US6943239B2 (en) 2005-09-13
DE69833106D1 (de) 2006-03-30

Similar Documents

Publication Publication Date Title
SE9701127D0 (sv) Antigenic fusionprotein carrying GALal, 3GAL epitopes
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
ES2132601T3 (es) Procedimiento para la seleccion de bacteriofagos especificos.
KR910002897A (ko) 에리트로포이에틴(epo)펩타이드 및 이에 대한 항체
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
BR9506059A (pt) Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico
ATE320448T1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
KR960022559A (ko) 슈도모나스 에루지노사 막 단백질로부터 유도된 면역원성 하이브리드 단백질 OprF-Oprl
EP0699755A3 (en) Process for obtaining modified immunoglobulins with reduced immunogenicity of the variable domains of a murine antibody, compositions containing them
DE69328489D1 (de) Stress-proteine epitopen
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
DK0871474T3 (da) Generering af humant insulin
ATE159532T1 (de) Verfahren zur reinigung von igg-monoklonalen antikörpern
WO2003088995A3 (en) Mucin fusion polypeptide vaccines, compositions and methods of use thereof
WO2003003986A3 (en) Parathyroid hormone antibodies and related methods
DE60222759D1 (de) Proteinsyntheseverfahren mit zellfreiem proteinsynthesesystem
SG95574A1 (en) Immunoreactive antigens of hepatitia e virus
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
AU2002363465A8 (en) Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
ATE162553T1 (de) Monoklonale antikörper gegen hepatitis-c-virus
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
AU5398898A (en) Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) and its use in diagnosis
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
DK0476059T3 (da) Fremgangsmåder til forøgelse af modificeringshastigheden for metastabile bindinger